99 Disruption of autophagy by increased 5-HT alters gut microbiota and enhances susceptibility to experimental colitis and Crohn’s disease.

98 Roe-inspired stem cell microcapsules for inflammatory bowel disease treatment.

97 Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease.

96 Telomere dysfunction instigates inflammation in inflammatory bowel disease.

95 NOD2 deficiency drives fibrosis and stricturing complications in Crohn’s disease through dysregulated homeostasis of activated fibroblasts and macrophages, which is ameliorated by gp130 blockade in human cell and zebrafish models.

94 Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway.

93 A fungus associated with human intestinal ulcers impairs wound healing via type 1 interferon pathways.

92 Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice.

91 Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation.

90 Bioadhesive hydrogels demonstrating pH-independent and ultrafast gelation promote gastric ulcer healing in pigs.

Free Images for Presentation: sunipix SUNIPIX